Optimal Number of Pleural Biopsies During Pleuroscopy
Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Mar 20, 2025
Trial Information
Current as of May 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to find out the best number of pleural biopsies that doctors should take during a procedure called pleuroscopy, which is used to examine the space around the lungs. This study is taking place at a single medical center and is currently recruiting participants. If you or a family member are 18 years or older and need pleuroscopy, you may be eligible to join the trial. However, those who cannot give informed consent due to health reasons will not be able to participate.
Participants in this study can expect to have pleuroscopy performed as usual, and the researchers will collect information on how many biopsies are taken and the outcomes of those procedures. This trial aims to improve patient care by helping doctors determine the optimal number of biopsies needed, which could lead to better diagnosis and treatment for pleural diseases. Your involvement could contribute to important findings that may benefit future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Consecutive patients who require pleuroscopies will be enrolled to the study.
- • Age ≥ 18
- Exclusion Criteria:
- • - Inability to provide informed consent
About Icahn School Of Medicine At Mount Sinai
The Icahn School of Medicine at Mount Sinai is a premier academic institution located in New York City, renowned for its commitment to advancing medical research, education, and patient care. As a leading sponsor of clinical trials, the institution leverages its state-of-the-art facilities and multidisciplinary expertise to drive innovative research initiatives aimed at improving health outcomes. With a focus on translational medicine, the Icahn School of Medicine collaborates with a diverse network of researchers, clinicians, and industry partners to explore novel therapies and interventions across a wide range of medical disciplines. Its rigorous scientific approach and dedication to ethical standards position it as a trusted leader in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Udit Chaddha
Principal Investigator
MBBS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported